ViewRay Systems, Inc. (VRAYQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 12, 2026

ViewRay Systems Company Description

ViewRay Systems, Inc. designs, manufactures, and markets magnetic resonance imaging radiation therapy system in the United States and internationally.

The company offers MRIdian A3i, an MRI-guided radiation therapy system that provides real-time 3D tissue tracking and automated beam control.

Its product is used for the treatment of pancreas, prostate, lung, liver, breast, and oligometastatic cancers.

The company was founded in 2004 and is headquartered in Oakwood, Ohio. On July 16, 2023, ViewRay, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

On October 26, 2023, the voluntary petition of ViewRay, Inc. for reorganization under Chapter 11 was converted to Chapter 7.

It had filed for Chapter 11 bankruptcy on July 16, 2023.

ViewRay Systems, Inc.
CountryUnited States
Founded2004
IndustryMedical Devices
SectorHealthcare
Employees295
CEOPaul Ziegler

Contact Details

Address:
2 Thermo Fisher Way
Oakwood, Ohio 44146
United States
Phone855 915 4558
Websiteviewraysystems.com

Stock Details

Ticker SymbolVRAYQ
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS92672L1070
SIC Code3845

Key Executives

NamePosition
Paul Ziegler Jr., J.D.President, Chief Executive Officer and Director
Dr. James F. Dempsey Ph.D.Founder and Chief Scientific Officer
Andrew James HillSenior Vice President of Operations and Development
Matt HarrisonDirector of Investor Relations
Sanket Shah J.D.Senior Vice President and General Counsel
Julianne MastVice President of Human Resources
Dr. Martin Fuss M.D., Ph.D.Chief Medical Officer
Adam PodbelskiSenior Vice President of Commercial Operations
Steven AnnenSenior Vice President of Global Marketing